Safety and immunogenicity of a novel 10-valent pneumococcal conjugate vaccine candidate in adults, toddlers, and infants in The Gambia-Results of a phase 1/2 randomized, double-blinded, controlled trial. (2020)
Attributed to:
IMPRINT: IMmunising PRegnant women and INfants neTwork
funded by
GCRF
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2019.08.072
PubMed Identifier: 31843266
Publication URI: http://europepmc.org/abstract/MED/31843266
Type: Journal Article/Review
Volume: 38
Parent Publication: Vaccine
Issue: 2
ISSN: 0264-410X